Cell division is one of the most fundamental processes in biology — it's how organisms grow, repair tissues, and maintain themselves. We've known about mitosis and meiosis for well over a century. But a research team studying the cellular mechanics of cancer has now described a third type of cell division that nobody had previously recognized. They're calling it klerokinesis.
The discovery was made by Mark Burkard and his colleagues at the University of Wisconsin. They were investigating what happens when cell division goes wrong in ways that can lead to cancer, specifically looking at how chromosomes are distributed between daughter cells during division. What they found was a process that doesn't fit neatly into either of the known division types: in klerokinesis, the chromosomes are distributed asymmetrically in a way that appears to be partly random — more like a lottery than the precise choreography of normal mitosis.
What Makes It Different
In normal mitosis, a cell carefully duplicates all its chromosomes and then distributes exactly one complete copy to each of the two daughter cells. The process is highly regulated and essentially deterministic. Klerokinesis, by contrast, involves a more stochastic sorting of genetic material, potentially leaving daughter cells with different chromosome complements. This kind of uneven distribution is associated with chromosomal instability — a hallmark of many cancers.
Understanding this newly described process could help explain why some cells spontaneously develop abnormal chromosome numbers, a condition called aneuploidy that's common in cancer cells and is thought to drive their aggressive behavior.
What It Means for Cancer Research
If klerokinesis is a real and consistent biological phenomenon, it opens up new questions about how cancer originates at the cellular level. Could some cells be predisposed to this kind of division? Could drugs be designed to suppress it? These are early days, and the findings were presented at a scientific meeting rather than published in a peer-reviewed journal at the time of reporting, so further validation is needed. But it's a genuinely intriguing lead in the ongoing effort to understand how cancer begins.
Source: ScienceAGoGo
0 comments:
Post a Comment